Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development Overview
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEW
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEW
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEW
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Your new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MORE
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MORE
"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLES
Professor of Medical Oncology and Director, Centre Leon Berard, EURACAN ERN LYRICAN, President, Unicancer
President, French Society of Nuclear Medicine and Professor of Medicine Toulouse University Institute of Cancer - Oncopole
Nuclear Safety and Security at the
Associate Professor of Nuclear Medicine, Department of Medicine and Surgery University of Milan Bicocca and President Elect, European Association of Nuclear Medicine (EANM)
Department of Nuclear Medicine at the University of Zurich
International Neuroendocrine Cancer Alliance (INCA) Representative and Patient Engagement, Education & Policy Lead, Neuroendocrine Cancer UK
Professor Emeritus, Economics Stockholm School of Economics
Head of Policy at the European Cancer
Global Director, RLT Policy Strategy Novartis
Hybrid event on 11 April 2024
European Parliament, Brussels ● Room JAN6Q1
In-person and virtual
This event will take place in the Central European time zone
Radioligand therapy (RLTs) is emerging as an essential pillar in cancer care and is a targeted treatment approach that has shown great value in gastroenteropancreatic neuroendocrine tumors and prostate cancer. It is also being researched as a promising treatment modality for several other advanced cancers. The scientific innovation on radioligand therapies is progressing rapidly, however, the healthcare system readiness for this modality is lagging. With the patient demand anticipated to increase, there is a critical and urgent need to enhance the understanding of the current level of readiness for RLT across countries, and to address issues impacting this readiness, to ensure that the appropriate patients receive this treatment in a timely and equitable manner.
IQVIA conducted research in 2023 using discussions and workshops with industry professionals with the aim to scope out these levers and begin identifying the capacity for RLTs in different European countries.
On behalf of MEP Niels Geuking (EPP, Germany), please join us in person or virtually for this public working session on preparing European infrastructure and healthcare systems for the latest advances in cancer care, hosted within the European Parliament in Brussels. This event is organized by the IQVIA Institute for Human Data Science with funding from Novartis.
